Zobrazeno 1 - 10
of 274
pro vyhledávání: '"D E, Karateev"'
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 0, Pp 51-67 (2020)
This systematic review focuses on the state-of-the-art pharmacotherapy of immune disorders in the novel coronavirus infection (COVID-19), leading to a cytokine storm and uncontrolled inflammatory response that causes severe tissue damage and multiple
Externí odkaz:
https://doaj.org/article/8370af0b97f0434a83de3b11eb2120f3
Autor:
A. V. Molochkov, D. E. Karateev, E. Yu. Ogneva, A. B. Zulkarnaev, E. L. Luchikhina, I. V. Makarova, D. Yu. Semenov
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 0, Pp 1-10 (2020)
Background: The COVID-19 pandemic is seriously affecting the society and economy of many countries, including the Russian Federation. Identifying of the major risk factors for an unfavorable outcome could help save lives and reduce the disease burden
Externí odkaz:
https://doaj.org/article/c642bb1b62624474a417f29691a63dca
Autor:
A. V. Molochkov, S. A. Terpigorev, A. V. Dreval, D. E. Karateev, A. V. Kildyushevsky, D. A. Kulikov, V. V. Likhvantsev, A. M. Ovezov, E. Yu. Ogneva, E. V. Smirnova, A. P. Faenko, Zh. S. Filippovskaya
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 0, Pp 73-90 (2020)
Externí odkaz:
https://doaj.org/article/ed977b55907a4c8b848e797a528dd2fe
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Медицинский совет, Vol 0, Iss 2, Pp 83-94 (2020)
The treatment of immuno-inflammatory rheumatic diseases has advanced significantly in recent decades due to development of biological medications, which, however, are not without some weak points. They include immunogenicity, parenteral administratio
Externí odkaz:
https://doaj.org/article/d436f289fd624aaa83673aaf04eef7cd
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Медицинский совет, Vol 0, Iss 18, Pp 85-91 (2019)
Despite progress in pharmacotherapy, there still are urgent needs in the development of new methods of drug therapy of rheumatoid arthritis (RA). New prospects for drug therapy are currently associated with sarilumab (SAR), recently registered in the
Externí odkaz:
https://doaj.org/article/f032542d9f5348adb7ad4fecc5b40f4e
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 461-469 (2019)
Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases in humans and is a serious medical and social problem in the Russian Federation. Current synthetic and biological agents acting through specific molecular targets, play a sign
Externí odkaz:
https://doaj.org/article/49285db5fd564f96835b462de5ca8922
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 383-392 (2019)
Background: Methotrexate is the main synthetic disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other immunoinflammatory conditions. In the recent years, the subcutaneous form of metho
Externí odkaz:
https://doaj.org/article/f5ce7276f303482b8e448dba529a6373
Autor:
G. P. Arutyunov, F. N. Paleev, O. M. Moiseeva, D. O. Dragunov, A. V. Sokolova, A. G. Arutyunov, I. V. Zhirov, O. V. Blagova, E. V. Privalova, S. A. Gabrusenko, A. A. Garganeeva, G. E. Gendlin, S. R. Gilyarevsky, D. V. Duplyakov, O. V. Zairatiants, D. E. Karateev, N. A. Koziolova, E. D. Kosmacheva, A. G. Kochetov, Yu. M. Lopatin, A. V. Melekhov, L. B. Mitrofanova, O. Yu. Narusov, S. N. Nasonova, A. V. Nedostup, S. Yu. Nikulina, Ya. A. Orlova, N. G. Poteshkina, A. P. Rebrov, M. A. Saidova, V. P. Sedov, V. E. Sinitsyn, M. Yu. Sitnikova, A. A. Skvortsov, V. V. Skibitsky, O. V. Stukalova, E. I. Tarlovskaya, S. N. Tereshchenko, V. Yu. Usov, I. V. Famin, A. I. Chesnikova, I. I. Shaposhnik, N. A. Shostak
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 11 (2021)
Russian Society of Cardiology (RSC)With the participation: Eurasian Association of Therapists (EUAT), Society of Specialists in Heart Failure (OSSN), Russian Scientific Medical Society of Therapists (RNMOT), Russian Society of Pathologists, Russian S
Externí odkaz:
https://doaj.org/article/185be48c349b41e29f3decabcad32532
Autor:
I. A. Guseva, M. Yu. Krylov, N. V. Demidova, A. S. Avdeeva, A. V. Smirnov, E. Yu. Samarkina, E. L. Luchina, D. E. Karateev, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 1, Pp 62-65 (2019)
The aim of the study was investigation of association of the rs7574865 polymorphism of STAT4 gene (Signal Transducer and Activator of Transcription 4, a family of signal transduction and transcription activation molecules 4) with very early rheumatoi
Externí odkaz:
https://doaj.org/article/38518f9897004a019e7722fe325b7291
Autor:
E. V. Udachkina, D. S. Novikova, T. V. Popkova, I. G. Kirillova, E. I. Markelova, Yu. N. Gorbunova, D. E. Karateev, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina, S. I. Glukhova, A. V. Volkov
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 4, Pp 449-455 (2018)
Rheumatoid arthritis (RA) is a disease with a high cardiovascular risk. The results of works on the impact of antirheumatic therapy on carotid artery (CA) intima-media thickness (IMT) are contradictory. Objective: to assess the time course of changes
Externí odkaz:
https://doaj.org/article/91c02c5ffd164a379cb6be690fcd330d